Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 14.90B | £ 14.73B | £ 13.60B | £ 11.87B | £ 15.79B |
Total Assets | £ 157.44B | £ 153.95B | £ 154.10B | £ 155.06B | £ 156.86B |
Total Debt | £ 75.58B | £ 67.18B | £ 69.52B | £ 66.80B | £ 68.82B |
Net Debt | £ 60.69B | £ 52.45B | £ 55.92B | £ 54.92B | £ 53.03B |
Total Liabilities | £ 99.70B | £ 96.98B | £ 96.05B | £ 97.25B | £ 97.28B |
Stockholders Equity | £ 55.45B | £ 54.69B | £ 55.89B | £ 55.80B | £ 58.36B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |